Matthew Gline - 10 Nov 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2026, 21:01:02 UTC
Prior SEC filing
20 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Sam Kaplan, as Attorney-in-Fact for Matthew Gline
Filing notes and source

Key filing fact

Matthew Gline filed Form 4 for Roivant Sciences Ltd. (ROIV) on 12 Nov 2026.

Key facts

  • This page summarizes Matthew Gline's Form 4 filing for Roivant Sciences Ltd. (ROIV).
  • 7 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 21:01.

Change

  • Previous filing in this sequence was filed on 20 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750094 Primary reporting owner

Gline Matthew

Relationship
CEO, Director
Address
C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature
By: /s/ Sam Kaplan, as Attorney-in-Fact for Matthew Gline
Signature date
12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Other

Transaction value
Shares
-25,841
Change %
-0.16%
Price
$40.43*
Shares after
16,523,295
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F3
ROIV transaction

Common Shares

Other

Transaction value
Shares
-32,490
Change %
-0.2%
Price
$41.13*
Shares after
16,490,805
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F4
ROIV transaction

Common Shares

Other

Transaction value
Shares
-30,083
Change %
-0.18%
Price
$41.63*
Shares after
16,460,722
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F5
ROIV transaction

Common Shares

Other

Transaction value
Shares
-18,905
Change %
-0.11%
Price
$42.01*
Shares after
16,441,817
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F6
ROIV transaction

Common Shares

Other

Transaction value
Shares
-41,179
Change %
-0.25%
Price
$40.36*
Shares after
16,400,638
Date
12 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F7
ROIV transaction

Common Shares

Other

Transaction value
Shares
-7,809
Change %
-0.05%
Price
$41.13*
Shares after
16,392,829
Date
12 Nov 2026
Ownership
Direct
Footnotes
F1, F2, F8
ROIV transaction

Common Shares

Tax liability

Transaction value
Shares
-1,600
Change %
-0.01%
Price
$41.85*
Shares after
16,391,229
Date
12 Nov 2026
Ownership
Direct
Footnotes
F2, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms.

Footnote F2

Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F5

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.87 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F6

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F7

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F8

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.96 to $41.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F9

Represents the "net settlement" by the Issuer of PSUs pursuant to the Issuer's nondiscretionary policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the Performance Condition and the Service Condition applicable to such PSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .